Confounding clinical presentation, complex disease pathways, a disparate healthcare ecosystem, and fragmented diagnostics pose some of healthcare’s most difficult diagnostic challenges. These are not unique to India but plague the world with devastating consequences. Poor access to near-point-of-care advanced solutions in infectious diseases, delays associated with a hub-and-spoke model of testing through centralised laboratories, and the complexity of cascading diagnostics in infectious diseases continue to challenge health systems across the world.
HaystackAnalytics identified a critical gap in this landscape - advanced clinical-grade diagnostics have existed but were inaccessible.
Through its expanding network of Genomic Centres of Excellence (GCEs), the company has demonstrated the power of distributive genomics in infectious disease diagnostics in India - a model where advanced clinical-grade, genomics-based diagnostics are not confined to a handful of specialised centres, but are embedded closer to the patients, hospitals, and clinicians who need them the most.
Over the next 12 months, HaystackAnalytics plans to scale the network to 100 centres across India, working towards rewriting the diagnostic playbook in infectious disease diagnostics.
At that scale, genomic infection diagnostics would become accessible across a far broader healthcare footprint. Hospitals that previously depended on distant specialised facilities or conventional approaches could gain access to advanced sequencing capabilities within their own diagnostic ecosystems, helping clinicians investigate complex infections closer to where patients are being treated.
“For decades, advanced diagnostics have largely followed a centralised model, where samples travel to specialised facilities and clinical teams wait for the answers. We believe genomics can change that equation by bringing sophisticated diagnostic capabilities closer to where healthcare is actually delivered.”
Gaurav Srivastava, COO and Co-founder, HaystackAnalytics